HIV/AIDS and Infectious Diseases
Show Only Open Trials
1.
Study Assessing Dolutegravir in HIV-1 Infected Subjects With Virus Resistant to Raltegravir and/or Elivitegravir (VIKING-4)
- Study Status: Open to Enrollment
- Sponsor: ViiV Healthcare
- Disease Status and/or Stage: Integrase Inhibitor Resistant
2.
A5298: A Randomized, Double-Blinded, Placebo-Controlled, Phase III Trial of the Quadrivalent HPV Vaccine to Prevent Anal Human Papillomavirus Infection in HIV-Infected Men
- Study Status: Open to Enrollment
- Sponsor: NIAID
- Disease Status and/or Stage: HIV-Positive MSM
- Protocol ID: A5298
3.
A5294: A Prospective, Phase III, Open-Label Study of Boceprevir, Pegylated-Interferon Alfa 2b and Ribavirin in HCV/HIV Coinfected Subjects
- Study Status: Open to Enrollment
- Sponsor: NIAID
- Disease Status and/or Stage: HIV/Hepatitis C Co-Infection
4.
START (STRATEGIC TIMING OF ANTIRETROVIRAL TREATMENT)
- Study Status: Open to Enrollment
- Sponsor: NIH
- Disease Status and/or Stage: HIV Antiretroviral Naive (Have Not Taken HIV Medications)
5.
A Phase 2a, Pilot, Open-Label Trial Evaluating the Safety, Tolerability and Pharmacodynamic Effects of GS-6624 in Subjects With Fibrosis of the Liver
- Study Status: Open to Enrollment
- Sponsor: Gilead Sciences
- Disease Status and/or Stage: Chronic Liver Disease and Liver Fibrosis of Any Cause
6.
A Randomized, Double-Blind, Phase 1b Study to Assess the Safety and Activity of the HCV Entry Inhibitor ITX 5061 in Treatment-Naive HCV Mono-Infected Adults
- Study Status: Open to Enrollment
- Sponsor: NIAID
- Disease Status and/or Stage: Treatment Naive Hepatitis C
7.
A5280: A Prospective Study Evaluating High-Dose Vitamin D and Calcium for Bone Health in HIV-Infected Individuals Initiating Highly Active Antiretroviral Therapy
- Study Status: Open to Enrollment
- Sponsor: NIAID
- Disease Status and/or Stage: HIV Antiretroviral Naive
8.
SAILING: A Study of GSK1349572 Versus Raltegravir (RAL) With Investigator Selected Background Regimen in Antiretroviral-Experienced, Integrase Inhibitor-Naive Adults
- Study Status: Closed to Enrollment
- Sponsor: ViiV Healthcare
- Disease Status and/or Stage: HIV, Currently Failing an Antiretroviral Therapy
9.
A5258: A Phase II, Double Blind, Randomized, Exploratory Study of Chloroquine for Reducing HIV-Associated Immune Activation
- Study Status: Open to Enrollment
- Sponsor: NIAID
